Oak Longevity GLP-1 Weight Loss Program – Personalized Clinical Telehealth Treatment

$119.00

Key Features

  • Clinician-Guided Treatment: Comprehensive online medical consultation and ongoing provider messaging.
  • Targeted Appetite Regulation: Formulated to help reduce hunger cravings and enhance satiety.
  • Multiple Treatment Options: Available in compounded injectable Semaglutide, Tirzepatide, branded pens, or oral tablets (subject to medical eligibility).
  • Home Delivery: Prescriptions shipped discreetly with required injection supplies or oral dosettes.
  • FSA/HSA Eligible: Qualified payment cards accepted for eligible clinical plans and medication costs.

Product Details

Brand Oak Longevity (Oak Longevity Holdings Corp.)
Product GLP-1 Weight Loss Treatment Plan
Type Prescription Telehealth Weight Management Program
Form Subcutaneous injection (vials or pre-filled pens) or oral tablets
Quantity 30-day supply per shipment (standard monthly refill cycle)
Ingredients / Active Agents Semaglutide or Tirzepatide (individual formulation determined by licensed provider; compounded or branded)
Suggested Use Take or administer once weekly (injections) or daily (oral formulations) exactly as directed by your prescribing clinician.
Manufacturer Sourced through licensed U.S. compounding and retail partner pharmacies.
Country of Origin United States

About the Oak GLP-1 Weight Loss

The Oak Longevity GLP-1 Weight Loss Program is an all-inclusive clinical telehealth solution designed to address the biological drivers of weight gain. Rather than relying on willpower or restrictive diets alone, this program combines modern metabolic medicine with direct clinician oversight. Through virtual medical evaluation, licensed providers identify suitable candidates and prescribe targeted GLP-1 (glucagon-like peptide-1) or dual GLP-1/GIP receptor agonist treatments, shipped directly to the patient’s home.

Key Benefits

  • Significant Appetite Reduction: Mimics natural incretin hormones to signal fullness to the brain, substantially curbing routine food cravings and caloric intake.

  • Delayed Gastric Emptying: Slows digestion in the stomach, helping you stay full longer after moderate meals.

  • Support for Metabolic Efficiency: Promotes improved glycemic control, supporting steady cellular energy and balanced blood glucose levels.

  • Convenient Virtual Care: Complete health questionnaires and message with medical providers without traveling to an in-person clinic.

  • Ongoing Provider Support: Regular check-ins and dosage adjustments to manage side effects and maintain treatment efficacy over time.

What’s Inside / Ingredients

Depending on individual medical history, provider assessment, and medication availability, prescriptions may include:

  • Compounded Semaglutide: A GLP-1 receptor agonist formulated in licensed 503A/503B compounding pharmacies for once-weekly subcutaneous injection.

  • Compounded Tirzepatide: A dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist for once-weekly subcutaneous injection.

  • Branded GLP-1 Medications: Commercial pre-filled injector pens (such as Wegovy® or Ozempic® when prescribed and covered/available).

  • Oral Wegovy® / Semaglutide Tablets: Oral daily incretin formulations for qualifying patients who prefer a non-injectable route.

  • Administration Supplies: Syringes, alcohol swabs, and explicit dosing instructions included with all multi-dose injectable vials.

(Compounded medications use pharmaceutical-grade active ingredients but are not directly evaluated or approved by the FDA for safety or efficacy in compounded forms.)

How It Works

GLP-1 receptor agonists function by replicating the action of the body’s naturally occurring incretin hormones produced in the gut after eating.

  1. Hypothalamic Signaling: The active compounds bind to GLP-1 receptors in the appetite control centers of the brain, lowering perceived hunger and diminishing intrusive food thoughts.

  2. Gastric Transit Regulation: By moderately slowing down stomach emptying, nutrients are absorbed more gradually, extending feelings of physical satiety between meals.

  3. Glucose & Insulin Modulation: Stimulates glucose-dependent insulin secretion from the pancreas while suppressing excess glucagon release, supporting balanced metabolic processing.

How to Use Oak GLP-1 Weight Loss Medications

  • Medical Evaluation: Complete the digital health intake questionnaire and submit biometric details. A licensed healthcare clinician reviews your profile to authorize an appropriate prescription and dosage.

  • Dosage & Administration:

    • Injectable Vials / Pens: Administer subcutaneously (under the skin) once every 7 days into the abdomen, thigh, or upper arm. Rotate injection sites weekly.

    • Oral Formulations: Take once daily on an empty stomach with a small sip of water (up to 4 oz) at least 30 minutes before any food, other liquids, or other oral medications.

  • Titration Schedule: Treatment typically starts at a lower initial dose to allow gastrointestinal adjustment and gradually scales up over weeks as instructed by your provider.

  • Storage Instructions: Keep injectable medications refrigerated between 36°F and 46°F (2°C to 8°C). Protect from direct light and avoid freezing. Discard any frozen or expired solution.

Who Is It For?

  • Adults (18 years and older) with a Body Mass Index (BMI) of 30 or greater (obesity).

  • Adults with a BMI of 27 or greater who also have at least one weight-related metabolic condition (such as hypertension, elevated cholesterol, or insulin resistance).

  • Individuals seeking structured, medical-grade weight management under direct clinical telehealth supervision.

Who Should Avoid

  • Individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC).

  • Patients diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

  • Individuals with a history of severe hypersensitivity or allergic reaction to Semaglutide, Tirzepatide, or any formulation components.

  • Women who are pregnant, planning to become pregnant, or actively breastfeeding.

  • Patients with an active or previous history of pancreatitis, severe gastrointestinal disease (such as gastroparesis), or end-stage kidney failure unless specifically cleared by a specialist.

Important Information

  • Clinical Supervisions & Prescriptions: This product requires a valid prescription issued by a licensed medical provider following a telehealth clinical evaluation. It is not an over-the-counter dietary supplement.

  • Common Gastrointestinal Effects: Mild-to-moderate nausea, vomiting, diarrhea, constipation, abdominal discomfort, and acid reflux may occur, particularly during initial dose escalation. Staying well hydrated and eating smaller meals helps mitigate symptoms.

  • Compounding Disclosure: Compounded drug products are prepared by specialized pharmacies to meet patient needs during commercial drug shortages or specific clinician orders. They are not reviewed or approved by the U.S. FDA.

  • Non-Curative: Weight-management medications are intended as an adjunct to a reduced-calorie meal plan and increased physical activity. Individual results will vary based on adherence, metabolic profile, and lifestyle factors.

Why Choose Oak Longevity GLP-1?

  • Comprehensive Clinical Access: Connect directly with licensed doctors and medical providers without waiting weeks for in-office specialty visits.

  • Customized Dosing Pathways: From entry-level titrations to dual-action Tirzepatide or oral options, plans adapt to patient tolerances and clinical objectives.

  • Seamless Home Delivery: Prescriptions are dispensed and dispatched directly to your doorstep with all required injection materials and temperature-safe packaging.

  • Transparent Ongoing Support: Continuous provider messaging allows patients to report side effects, track biometrics, and calibrate their regimen safely over time.

Frequently Asked Questions

Is a prescription required for Oak GLP-1 Weight Loss?

Yes. All GLP-1 medications provided through Oak Longevity are prescription drugs. You must complete an online medical intake and receive approval from a licensed healthcare clinician before medication is dispensed.

How is the medication administered?

Most GLP-1 therapies are administered once per week as a small subcutaneous injection under the skin of the stomach, thigh, or upper arm using a fine insulin needle. For qualified patients, daily oral tablet alternatives may also be prescribed.

What is the difference between Semaglutide and Tirzepatide?

Semaglutide is a single GLP-1 receptor agonist that targets appetite pathways. Tirzepatide is a dual agonist targeting both GLP-1 and GIP receptors, providing two synergistic metabolic pathways to regulate satiety and blood sugar. Your clinician will advise which option fits your clinical profile.

Are compounded GLP-1 medications FDA approved?

No. While the active pharmaceutical ingredients and manufacturing facilities adhere to strict pharmacy quality regulations (503A/503B state board oversight), compounded prescription formulations themselves do not undergo individual FDA pre-market approval.

How quickly does the medication arrive once approved?

Once your consultation is finalized and the prescription is authorized by your provider, the partner pharmacy prepares and ships the medication directly to your address, typically arriving within a few business days.

Can I use my HSA or FSA to pay for Oak GLP-1?

Yes. Clinical telehealth consultations and prescription weight-loss medications are generally considered qualified medical expenses eligible for HSA and FSA reimbursement.

Final Verdict

The Oak Longevity GLP-1 Weight Loss Program bridges the gap between modern clinical endocrinology and everyday convenience. By combining prescription-strength GLP-1 and GIP therapies with licensed medical oversight and doorstep fulfillment, it delivers a clinically grounded, sustainable approach to metabolic health and long-term weight management.